by Cara Murez Infectious disease experts are warning that a shortage of a key antibiotic for treating the sexually transmitted infection syphilis could make it hard to fight the spread of the disease. The United States already has a big problem with syphilis, with cases rising for more than 20 years. Cases increased nearly 75%...
Oriana González Illustration: Annelise Capossela/Axios The Centers for Disease and Prevention on Thursday recommended adults aged 60 and older get one of two respiratory syncytial virus vaccines this fall, making them the first shots against the disease to be authorized in the U.S. Driving the news: The vaccines from GlaxoSmithKline and Pfizer shots have been...
Tyler Patchen News Reporter Pfizer has notified the FDA that there may be an impending shortage of penicillin, citing an increase in syphilis infections and other shortages. In a letter posted to the FDA’s website and dated Monday, the pharma said there is “limited supply” and an “impending stock out situation” for prefilled Bicillin L-A...
Credit: Pixabay/CC0 Public Domain US pharmaceutical giant Pfizer has obtained positive results in late-stage testing for a nasal spray designed to treat migraines, a study showed Thursday. Pfizer said the study, which has been peer-reviewed and published in The Lancet Neurology journal, showed the company’s drug zavegepant had proven to be “effective in the acute...
By Neha Mathur Jan 3 2023 Reviewed by Emily Henderson, B.Sc. In a recent scientific paper published in the journal Nature Microbiology, researchers reproduced two target trials using electronic health records (EHRs) of the Department of Veterans Affairs (VA) to compare the effectiveness of the third dose of BNT162b2 or messenger ribonucleic acid (mRNA)-1273 vaccine among...
Delilah Alvarado Associate Editor The exterior of the Food And Drug Administration headquarters is seen on July 20, 2020, in White Oak, Maryland. Sarah Silbiger via Getty Images The Food and Drug Administration has authorized updated COVID-19 booster vaccines for emergency use, hoping the reformulated shots from partners Pfizer and BioNTech and Moderna can curb an...
Three US studies offer more evidence that third dose of COVID vaccine is highly effective against Omicron. A healthcare worker receives a Pfizer COVID-19 booster shot in the United States [File: Lynne Sladky/AP]Published On 22 Jan 202222 Jan 2022 Booster shots of the Pfizer-BioNTech and Moderna vaccines have proven highly effective at preventing Omicron-related hospitalisations, according to...
by Tamar Nordenberg, Veterans Affairs Research Communications Credit: Pixabay/CC0 Public Domain In the first head-to-head comparison of the effectiveness of the Pfizer-BioNTech and Moderna COVID-19 vaccines, researchers examined the electronic health records of veterans who had received each vaccine. Both vaccines were highly effective in preventing COVID-19 outcomes such as documented infection, hospitalization, and death....
Credit: Unsplash/CC0 Public Domain People who received Johnson & Johnson’s COVID-19 vaccine may benefit from a booster dose of Pfizer or Moderna, preliminary results of a US study published Wednesday showed. The study, funded by the National Institutes of Health (NIH), was eagerly awaited in the United States because it looked at the possibility of...
Jeff Evans September 16, 2021 Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Patients with rheumatoid arthritis in remission had a rate of flare following vaccination with the Pfizer/BioNtech COVID-19 vaccine that appears to be on par with rates seen with other vaccines in patients with RA, according to results from a small Italian...
